Iovance Biotherapeutics, Inc. · NASDAQ:IOVA

BlackRock, Inc. reported a 7.50% stake in Iovance Biotherapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 28, 2026

BlackRock, Inc. reported a 7.50% stake in Iovance Biotherapeutics, Inc., 33,366,587 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G/A).

Stake
7.50%
Shares
33,366,587
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.7.50%33,366,587

Source

View original at SEC

Related